Status:
UNKNOWN
A Novel Argon Laser Iridoplasty for Pigment Dispersion Syndrome
Lead Sponsor:
Fayoum University
Conditions:
Pigment Dispersion Syndrome
Pigmentary Glaucoma
Eligibility:
All Genders
20-85 years
Phase:
NA
Brief Summary
Pigment dispersion syndrome is a rare condition where anomalous iris configuration leads to posterior iris bowing with subsequent friction with the lenticulozonular unit resulting in dispersion of pig...
Detailed Description
\*Study design: Interventional, longitudinal, prospective, uncontrolled case series study \*\*Methods: * Population: cases of pigment dispersion syndrome/glaucoma. * Sample size: Not determined sin...
Eligibility Criteria
Inclusion
- Pigment dispersion syndrome/glaucoma confirmed by either clinical signs or imaging with documented posterior iris bowing.
Exclusion
- Active or history of Uveitis.
- Pupil size \> 7mm in mesopic conditions.
- Previous Iris-based laser procedures e.g. Iridotomy, Iridoplasty
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05231928
Start Date
December 1 2021
End Date
February 1 2023
Last Update
July 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fayoum University Hospitals
Al Fayyum, Egypt